Molecular genetics of the fibrinolytic and coagulation systems in haemostasis, thrombogenesis, restenosis and atherosclerosis

Current Opinion in Lipidology

Volumn 8, Issue 2, 1997, Pages 118-125

  Carmeliet, Peter ^a   Collen, Désiré ^a  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ATHEROSCLEROSIS; BLOOD CLOT LYSIS; BLOOD CLOTTING; FIBRIN DEPOSITION; FIBRINOLYSIS; GENE TARGETING; GENE THERAPY; GENE TRANSFER; HEMOSTASIS; INTIMA; MOLECULAR GENETICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; RESTENOSIS; REVIEW; THROMBOGENESIS; THROMBOSIS; TRANSGENIC MOUSE; VASCULAR DISEASE;

ANIMALS; ARTERIOSCLEROSIS; BLOOD COAGULATION; FIBRINOLYSIS; HEMOSTASIS; HUMANS; MICE; MICE, TRANSGENIC; NEOVASCULARIZATION, PHYSIOLOGIC; THROMBOSIS;

EID: 0030924624     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199704000-00010     Document Type: Review

References (46)

1. Edgington TS, Mackman N, Brand K, Ruf W: The structural biology of expression and function of tissue factor. Thromb Haemost 1991, 66:67-79.
2. Furie B, Furie BC: The molecular basis of blood coagulation. Cell 1988, 53:505-518.
3. Davie E: Biochemical and molecular aspects of the coagulation cascade. Thromb Haemost 1995, 74:1-6.
4. Collen D, Lijnen HR: Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 1991, 78:3114-3124.
5. Schneiderman J, Loskutoff DJ: Plasminogen activator inhibitors. Trends Cardiovasc Med 1991, 1:99-102.
6. Wiman B: Plasminogen activator inhibitor 1 in plasma: its role in thrombotic disease. Thromb Haemost 1995, 74:71-76.
7. Vassalli JD: The urokinase recep tor. Fibrinolysis 1994, 8(suppl 1): 172-181.
8. Risau W. Differentiation of the endothelium. FASEB J 1995, 9:926-933.
9. Carmeliet P, Ferreira V, Breier G, Pollefeyt S, Kieckens L, Gertsenstein M, Fahrig M, Vandenhoeck A, Harpal K, Eberhardt C et al.: Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 1996, 380:435-439. Genetic evidence for a strict gene dosage-dependent role of vascular endothelial growth factor in blood vessel development using novel embryonic stem cell technologies is provided.
10. Carmeliet P, Mackman N, Moons L, Luther T, Gressens P, Van Vlaenderen I, Demunck H, Kasper M, Breier G, Evrard P et al.: Role of the cellular receptor tissue factor in embyonic vessel development. Nature 1996, 383:73-75. Study on the role of TF in blood vessel development, providing genetic evidence for a nonhaemostatic role of TF beyond haemostasis.
11. 2+ signals in J82 cells, transfected COS-1 cells, Madin-Darby canine kidney cells and in human endothelial cells induced to synthesise tissue factor. J Biol Chem 1995, 270:4650-4660.
12. Toomey JR, Kratzer KE, Lasky NM, Stanton JJ, Broze GJ Jr: Targeted disruption of the murine tissue factor gene results in embryonic lethality. Blood 1996, 88:1583-1587.
13. Bugge TH, Xiao Q, Kombrinck K, Flick MJ, Holmback K, Danton MJS, Colbert MC, Witte DP, Fujikawa K, Davie EW, Degen J: Fatal embryonic bleeding events in mice lacking tissue factor, the cell-associated initiator of blood coagulation. Proc Natl Acad Sci U S A 1996, 93:6258-6263.
14. Cui J, Sue O'Shea K, Purkayastha A, Saunders TL, Ginsburg D: Fatal haemorrhage and incomplete block to embryogenesis in mice lacking coagulation factor V. Nature 1996, 384:66. Study providing genetic evidence for a nonhaemostatic role of factor V in embryogenesis.
15. Conolly A, Ishihara H, Kahn ML, Farese RV, Coughlin SR: Role of the thrombin receptor in development and evidence for a second receptor. Nature 1996, 381:516-519 Evidence was provided for a morphogenic role of the thrombin receptor beyond haemostasis.
16. Bi L, Lawler AM, Antonarakis SE, High KA, Gearhart JD, Kazazaian HH Jr: Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A. Nature Genet 1995, 10:119-121.
17. Suh TT, Holmback K, Jensen NJ, Daugherty CC, Small K, Simon DI, Potter SS, Degen JL: Resolution of spontaneous bleeding events but failure of pregnancy in fibrinogen deficient mice. Genes Devel 1995, 9:2020-2033.
18. Aoki N: Hemostasis associated with abnormalities of fibrinolysis. Blood Rev 1989, 3:11-17.
19. Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan R: Physiological consequences of loss of plasminogen activator gene function in mice. Nature 1994, 368:419-424.
20. Ploplis V, Carmeliet P, Vazirzadeh S, Van Vlaenderen I, Moons L, Plow E, Collen D: Effects of disruption of the plasminogen gene on thrombosis, growth and health in mice. Circulation 1995, 92:2585-2593.
21. Bugge TH, Flick MJ, Daugherty CC, Degen JL: Plasminogen deficiency causes severe thrombosis but is compatible with development and reproduction. Genes Devel 1995, 9:794-807.
22. Bugge TH, Flick MJ, Danton MJ, Daugherty CC, Romer J, Dano K, Carmeliet P, Collen D, Degen JL: Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci U S A 1996, 93:5899-5904. The authors provide genetic evidence that the u-PA can function in the absence of its cellular receptor.
23. Romer J, Bugge TH, Pyke C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nature Med 1996, 2:287-292. Study providing genetic evidence for the role of plasminogen in skin wound healing.
24. Kitching AR, Holdsworth SR, Ploplis V, Plow E, Collen D, Carmeliet P. Tipping P: Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis. J Exp Med 1977 (In press).
25. Carmeliet P, Moons, Ploplis V, Plow EF, Collen D: Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J Clin Invest 1997, 99:2746-2755. Study providing genetic evidence for the role of plasminogen in smooth muscle cell migration during arterial neointima formation.
26. Carmeliet P, Kieckens L, Schoonjans L, Ream B, Van Nuffelen A, Prendergast G, Cole M, Bronson R, Collen D, Mulligan RC: Plasminogen activator inhibitor-1 gene deficient mice. I. Generation by homologous recombination and characterization. J Clin Invest 1993, 92:2746-2755.
27. Carmeliet P, Stassen JM, Schoonjans L, Ream B, van den Oord JJ, De Mol M, Mulligan RC, Collen D: Plasminogen activator inhibitor-1 gene deficient mice. II. Effects on haemostasis, thrombosis and thrombolysis. J Clin Invest 1993, 92:2756-2760.
28. Carmeliet P, De Clercq C, Janssen S, Polleleyt S, Bouché A, Wijns S, Mulligan RC, Collen D: Biological effects of disruption of the tissue-type plasminogen activator, urokinase-type plasminogen activator and plasminogen activator inhibitor-1 genes in mice. Ann N Y Acad Sci 1995, 748P:367-381.
29. Liu AC, Lawn RM: Lipoprotein(a) and atherogenesis. Trends Cardiovasc Med 1994, 4:40-44.
30. Palabrica TM, Liu AC, Aronowitz MJ, Furie B, Lawn RM, Furie BC: Antifibrinolytic activity of apolipoprotein (a) in vivo: human apolipoprotein (a) transgenic mice are resistant to tissue plasminogen activator-mediated thrombolysis. Nature Med 1995, 1:256-259.
31. Carmeliet P, Stassen JM, Meidell R, Collen D, Gerard R: Adenovirus-mediated gene transfer of rt-PA restores thrombolysis in t-PA deficient mice [Abstract]. Fibrinolysis 1994, 8:282.
32. Libby P, Schwartz D, Brogi E, Tanaka H, Clinton SK: A cascade model for restenosis. A special case of atherosclerotic progression. Circulation 1992, 86(suppl III):III47-III52.
33. Clowes AW, Reidy MA: Prevention of stenosis after vascular reconstruction: pharmacologic control of intima hyperplasia - a review. J Vasc Surg 1991, 13:885-891.
34. Simpson AJ, Booth NA, Moore NR, Bennett B: Distribution of plasminogen activator inhibitor (PAM) in tissues. J Clin Pathol 1991, 44:139-143.
35. Clowes AW, Clowes MM, An YPT, Reidy MA, Belin D: Smooth muscle cells express urokinase during mitogenesis and tissue-type plasminogen activator during migration in injured rat carotid artery. Circ Res 1990, 67:61-67.
36. Carmeliet P, Moons L, Stassen JM, van den Oord JJ, Declercq C, Kockx M, Collen D: A model for arterial neointima formation using perivascular electric injury in mice. Am J Pathol 1997, 150:761-776.
37. Dewerchin M, Van Nuffelen Wallays G, Bouché A, Moons L, Carmeliet P, Mulligan RCM, Collen D: Generation and characterization of urokinase receptor deficient mice. J Clin Invest 1996, 97:870-878.
38. Carmeliet P, Moons L, Dewerchin M, Ploplis V, De Mol M, Stassen JM, Declercq C, Plow E, Gerard R, Collen D: Receptor-independent plasminogen activation by urokinase-type plasminogen activator promotes and adenoviral PAM gene transfer inhibits arterial neointima formation in mice [Abstract]. Fibrinolysis 1996, 10(suppl 3):57.
39. Stefansson S, Lawrence D: The serpin PAM inhibits cell migration by blocking integrin avβ3 binding to vitronectin. Nature 1996, 383:441-443.
40. Hamsten A, Erlksson P: Fibrinolysis an atherosclerosis: an update. Fibrinolysis 1994, 8(suppl 1):253-262
41. Schneiderman J, Sawdey MS, Keeton MR, Bordin GM, Bernstein EF, Dilley RB, Loskutoff DJ: Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc Natl Acad Sci U S A 1992, 89:6998-7002.
42. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Thinnes T, Bernstein EF, Dilley RB, Loskutoff DJ: Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 1995, 96:639-645. Evidence that increased plasmin proteolysis may participate in aneurysm formation is provided.
43. Lupu F, Heim DA, Bachmann F, Hurni M, Kakkar VV, Kruithof EKO: Plasminogen activator expression in human atherosclerotic lesions. Arterioscler Thromb Vasc Biol 1995, 15:1444-1455. Increased plasmin proteolysis may participate in aneurysm formation.
44. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL: Severe hypercholesterolemia and atherosclerosis in apolipoprotein E deficient mice created by homologous recombination in ES cells. Cell 1992, 71:343-353.
45. Shi C, Russel ME, Bianchi C, Newell JB, Haber E: Murine model of accelerated transplant atherosclerosis. Circ Res 1994, 75: 199-207.
46. Ploplis V, French E, Carmeliet P, Collen D, Plow E: The plasminogen system and cell migration during an inflammatory response [Abstract]. Fibrinolysis 1996, 10(suppl 3):55.